Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A European Multicenter Study
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.70078 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Aglaia Chalkia und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Interstitial lung disease (ILD) can occur in association with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV‐ILD) or as an isolated entity with positive ANCA (ANCA‐ILD). However, data on the epidemiology and outcomes of these conditions remain limited.
Methods
A European multicenter retrospective study encompassed patients with AAV‐ILD or ANCA‐ILD. Baseline and subsequent chest computed tomography studies were centrally reviewed. Primary outcomes included forced vital capacity % (FVC%) decline, respiratory failure, and mortality.
Results
Of 162 patients (myeloperoxidase [MPO]–ANCA 85%), 123 (76%) had AAV‐ILD and 39 (24%) ANCA‐ILD. At baseline, usual interstitial pneumonia (UIP) was the most frequent radiologic pattern (57%), whereas half had a radiologic fibrosis grade >10%. Kidney involvement was present in 73%, most commonly Berden focal class. UIP and nonspecific interstitial pneumonia (NSIP) patterns showed greater annual FVC% decline than other patterns (UIP −1.99%, NSIP −3.76% [ P = 0.35], others +0.36%). An adjusted mixed‐effects model indicated that rituximab was associated with mean FVC% improvement at 12 months (+6.02%; P = 0.07). Radiologic progression occurred in ~50%, mainly in younger patients with a higher fibrosis severity grade. Respiratory failure (19%) was associated with fibrosis severity (grade 4 hazard ratio [HR] 4.7, P = 0.029) and baseline FVC% (HR 0.95, P = 0.002). Over a median 4.2‐year follow‐up, 48% died. Age (HR 1.08, P = 0.04) and baseline FVC% (HR 0.97, P = 0.05) were independent predictors of mortality.
Conclusion
At baseline, higher fibrosis severity, UIP, and lower FVC% were associated with worse outcomes. Immunosuppressives, such as rituximab, may help preserve lung function. The need for early identification and individualized treatment in ILD associated with AAV or ANCA is underscored. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Cambridge, United Kingdom.
- Nephrology Department, General Hospital of Athens Hippokration, Athens, Greece.
- Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
- Department of Radiology, University of Cambridge, Cambridge, United Kingdom.
- Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, Attikon University Hospital and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Vasculitis and Lupus Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
ORCID-Profile: Aglaia Chalkia, Timothy J Sadler, Sara Monti, Dimitrios Vassilopoulos, David Jayne
Zitieren
APA
Chalkia, A., Kotnik, M., Sadler, T. J., Katechis, S., Jones, R., Kamath, A., Mohammad, A. J., Monti, S., Mukhtyar, C., Nanda, V., Petrakis, I., Petras, D., Sinha, A., Sivasothy, P., Smith, R., Stylianou, K., Vassilopoulos, D., Babar, J., & Jayne, D. (2026). Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A European Multicenter Study. Arthritis & Rheumatology. https://doi.org/10.1002/art.70078
Vancouver
Chalkia A, Kotnik M, Sadler TJ, Katechis S, Jones R, Kamath A, et al. Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A European Multicenter Study. Arthritis & Rheumatology. 2026. doi:10.1002/art.70078
BibTeX
@article{Chalkia2026,
author = {Chalkia, Aglaia and Kotnik, Marusa and Sadler, Timothy J and Katechis, Spyridon and Jones, Rachel and Kamath, Ajay and Mohammad, Aladdin J and Monti, Sara and Mukhtyar, Chetan and Nanda, Viral and Petrakis, Ioannis and Petras, Dimitrios and Sinha, Ashnish and Sivasothy, Pasupathy and Smith, Rona and Stylianou, Kostas and Vassilopoulos, Dimitrios and Babar, Judith and Jayne, David},
title = {Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A European Multicenter Study},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70078}
}
EUVIMED